Dan A. Giampuzzi

Dan A. Giampuzzi

Plus aucun poste en cours

Health Technology
Consumer Services
Finance

Profil

Mr. Giampuzzi most recently served as President and CEO of Gemin X Biotechnologies Inc., a Montreal/Philadelphia-based private biotechnology company that specializes in the discovery and development of novel small molecule cancer therapeutics based on the regulation of apoptosis, the body's natural ability to destroy injured or damaged cells.
During his nine years at Gemin X, he successfully raised over $100 million in private venture capital financing from international firms and assembled a highly capable team that has put over 12 cancer drugs into the clinic and six onto the market today.
Previous to Gemin X he worked in senior management roles for such organizations as MDS Capital Corp., Searle Canada Inc. and Merrell Dow Pharmaceuticals.
Mr. Giampuzzi earned a Bachelor of Science and an MBA from the University of Toronto.

Anciens postes connus de Dan A. Giampuzzi

SociétésPosteFin
Private Equity Investor 01/12/2008
President 31/07/2007
Voir l'expérience en détail de Dan A. Giampuzzi

Formation de Dan A. Giampuzzi

University of Toronto Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Dan A. Giampuzzi

Relations

17

Relations au 1er degré

3

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées2

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Dan A. Giampuzzi